2015 37a VTE Risk Reduction Flashcards

1
Q

When should VTE risk assessment be undertaken?

A
  1. Prepregnancy
  2. Early pregnancy
  3. Hospital admission
  4. Intrapartum
  5. Postpartum
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which women should be given LMWH throughout pregnancy & then 6 weeks postnatally?

A

4+ risk factors
Previous VTE unprovoked by major surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which women should receive LMWH from 28 weeks to 6 weeks PN?

A

3 risk factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which women should receive LMWH for 10 days postpartum?

A

2 risk factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the antenatal risk factors for VTE?

A
  1. BMI > 30
  2. Age > 35
  3. Parity ≥ 3
  4. Smoker
  5. Gross varicose veins
  6. Current PET
  7. Immobility eg paraplegia, PGP
  8. Family hx VTE
  9. Low-risk thrombophilia
  10. Multiple pregnancy
  11. IVF/ART
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the transient risk factors for VTE?

A
  1. Dehydration
  2. Hyperemesis
  3. Current systemic infection
  4. Long-distance travel
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the intermediate risk factors for which LMWH is considered in pregnancy?

A
  1. Hospital admission
  2. Single previous provoked VTE
  3. High-risk thrombophilia, no VTE
  4. Medical comorbidities
  5. Surgical procedure
  6. OHSS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

For which medical comorbidities is LMWH considered?

A
  1. Cancer
  2. Heart failure
  3. Active SLE
  4. Inflammatory bowel disease
  5. Inflammatory polyarthropathy
  6. Nephrotic syndrome
  7. Type 1 DM with nephropathy
  8. Sickle cell disease
  9. Current IVDU
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which women need 6 weeks postnatal LMWH?

A
  1. Anyone requiring antenatal LMWH
  2. Any previous VTE
  3. High-risk thrombophilia
  4. Low-risk thrombophilia + FHx
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the intermediate risk factors needing 10 days postnatal LMWH?

A
  1. CS in labour
  2. BMI ≥ 40
  3. Readmission or prolonged PN admission
  4. Surgical procedure in puerperium other than immediate perineal repair
  5. Medical comorbidities
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What additional postnatal risk factors score for VTE risk?

A
  1. Elective CS
  2. Current systemic infection
  3. Preterm delivery < 37+0
  4. Stillbirth
  5. Mid-cavity rotational or OVB
  6. Prolonged labour > 24 hours
  7. PPH > 1L or blood transfusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which heritable thrombophilia needs a higher dose of LMWH & how is this managed?

A

Antithrombin deficiency
50%, 75% or full treatment dose
In collaboration with haematologist
Consider anti-Xa monitoring, aim 4-hour peak level 0.5-1.0 units/ml
Consider antithrombin replacement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which acquired thrombophilia needs a higher dose of LMWH, and how much?

A

Antiphospholipid syndrome
50%, 75% or full treatment dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which asymptomatic heritable thrombophilias should be referred to a local expert, be considered for antenatal LMWH & given 6 weeks PN?

A
  1. Protein C deficiency
  2. Protein S deficiency
  3. Homozygous factor V Leiden
  4. Homozygous prothrombin gene mutation
  5. Compound heterozygotes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How should LMWH be managed at delivery?

A
  1. Stop if any PVB
  2. Avoid RA for > 12 hours after dose, or 24 for therapeutic dose
  3. Avoid LMWH for > 4 hours after spinal
  4. Stop day before elective CS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What risk factors for haemorrhage may indicate TEDS or UFH over LMWH?

A
  1. Major APH
  2. Coagulopathy
  3. Progressive wound haematoma
  4. Suspected intra-abdominal bleed
  5. PPH
17
Q

If women on warfarin are converted to LMWH in pregnancy, how is the conversion back managed?

A

5-7 days after delivery
With bridging

18
Q

What is the calf pressure of TEDS?

19
Q

By how much does LMWH reduce VTE risk?

20
Q

What is the UK incidence of PE?

A

1.3 in 10,000

21
Q

What is the UK incidence of VTE in pregnancy & the puerperium?

A

1-2 in 1000

22
Q

What are the benefits of LMWH over UFH?

A
  1. Just as effective
  2. Risk of heparin-induced thrombocytopenia much lower
  3. Lower risk of osteoporosis & fractures
23
Q

What are the benefits of UFH over LMWH?

A
  1. Shorter half-life
  2. More complete reversal of activity by protamine sulphate
24
Q

What is the dosing regime for enoxaparin?

A

< 50 kg 20mg OD
50-90kg 40mg OD
91-130kg 60mg OD
131-170kg 80mg OD
>170kg 0.6 mg/kg/d

25
What is the dosing regime for dalteparin?
< 50 kg 2500 units OD 50-90kg 5000 units OD 91-130kg 7500 units OD 131-170kg 10,000 units OD >170kg 75 units/kg/d
26
What is the dosing regime of tinzaparin?
75 units/kg/day < 50 kg 3500 units 50-90kg 4500 units 91-130kg 7500 units 131-170kg 9000 units >170kg 75 units/kg/d
27
What are the characteristics of warfarin embryopathy?
1. Hypoplasia of nasal bridge 2. Congenital heart defects 3. Ventriculomegaly 4. Agenesis of corpus callosum 5. Stippled epiphyses
28
What proportion of fetuses exposed to warfarin between 6 & 12 weeks of gestation develop warfarin embryopathy?
Approx 5%
29
What are the contraindications/cautions to LMWH use?
1. Known bleeding disorders 2. Active AN or PN bleeding 3. Increased risk major bleed eg placenta praevia 4. Thrombocytopenia < 75 5. Acute stroke in previous 4 weeks 6. Severe renal disease 7. Severe liver disease 8. Uncontrolled HTN, > 200/120